(Q53879367)

22 May 2018

title

Intranasal delivery of recombinant human parathyroid hormone [hPTH (1-34)], teriparatide in rats. (English)

1 reference

22 May 2018

author

Remigius Agu

1

1 reference

22 May 2018

author name string

Satyanarayana Valiveti

2

1 reference

22 May 2018

D Caroline Earles

3

1 reference

22 May 2018

Mitchell Klausner

4

1 reference

22 May 2018

Patrick J Hayden

5

1 reference

22 May 2018

Daniel P Wermeling

6

1 reference

22 May 2018

Audra L Stinchcomb

7

1 reference

22 May 2018

publication date

1 August 2004

1 reference

22 May 2018

published in

Endocrine Research

1 reference

22 May 2018

volume

30

1 reference

22 May 2018

issue

3

1 reference

22 May 2018

page(s)

455-467

1 reference

22 May 2018

Pharmacological regulation of parathyroid hormone secretion

cites work

1 reference

https://api.crossref.org/works/10.1081%2FERC-200035957

A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200035957

Management of primary osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200035957

Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200035957

Developments in parathyroid hormone and related peptides as bone-formation agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200035957

Pulmonary delivery of drugs for bone disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200035957

Nasal delivery. The use of animal models to predict performance in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FERC-200035957

21 January 2018

Identifiers

DOI

10.1081/ERC-200035957

1 reference

22 May 2018

1 reference

22 May 2018